In a letter to US Trade Representative Ron Kirk, ten members of Congress have asked for a meeting to discuss “the approach your office is considering for the Trans-Pacific Partnership Trade Agreement negotiations that would undermine public health and access to medicines in the developing countries negotiating that agreement.”  They are concerned over reports that USTR is considering the expansion of patentability and data exclusivity requirements, the prohibition of pre-grant opposition to patents, and the inclusion of a pharmaceutical chapter that would “limit the ability of governments to negotiate with dru makers and set reimbursement rates.”  The letter was signed by Reps. Schakowsky, Payne, Waters, Jackson, Grijalva, Conyers, DeLauro, Woolsey, Lee and Michaud.  Click here for the full letter.